About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Canadian Agency for Drugs and Technologies in Health
›
top-articles
Canadian Agency for Drugs and Technologies in Health
220
(top 1%)
papers
21.1K
(top 1%)
citations
42
(top 1%)
h
-index
146
(top 0.1%)
g
-index
231
all documents
25.2K
doc citations
4.6K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Annals of Internal Medicine
2018
15,209
2
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies
JAMA - Journal of the American Medical Association
2018
1,783
3
THE EFFECT OF ENGLISH-LANGUAGE RESTRICTION ON SYSTEMATIC REVIEW-BASED META-ANALYSES: A SYSTEMATIC REVIEW OF EMPIRICAL STUDIES
International Journal of Technology Assessment in Health Care
2012
804
4
Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
Value in Health
2014
742
5
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review
Medical Journal of Australia
2006
725
6
Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews
Journal of Clinical Epidemiology
2021
488
7
Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions
JAMA - Journal of the American Medical Association
2009
293
8
Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval
Clinical Pharmacology and Therapeutics
2012
230
9
The new definition of health technology assessment: A milestone in international collaboration
International Journal of Technology Assessment in Health Care
2020
215
10
Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis
Cmaj
2009
208
11
Home telehealth for diabetes management: a systematic review and meta‐analysis
Diabetes, Obesity and Metabolism
2009
204
12
Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta‐Analysis
Headache
2015
197
13
Home telemonitoring for congestive heart failure: a systematic review and meta-analysis
Journal of Telemedicine and Telecare
2010
188
14
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
BMJ, The
2013
158
15
Home telehealth for chronic disease management: A systematic review and an analysis of economic evaluations
International Journal of Technology Assessment in Health Care
2009
147
16
Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism
JAMA - Journal of the American Medical Association
2014
126
17
Priority setting for health technology assessments: A systematic review of current practical approaches
International Journal of Technology Assessment in Health Care
2007
114
18
RAPID REVIEW: AN EMERGING APPROACH TO EVIDENCE SYNTHESIS IN HEALTH TECHNOLOGY ASSESSMENT
International Journal of Technology Assessment in Health Care
2014
112
19
The prevalence of patient engagement in published trials: a systematic review
Research Involvement and Engagement
2018
101
20
Canadian Guidelines for Economic Evaluation of Pharmaceuticals
Pharmacoeconomics
1996
98
21
Rapid review programs to support health care and policy decision making: a descriptive analysis of processes and methods
Systematic Reviews
2015
95
22
Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
BMJ Open
2014
93
23
Translating Knowledge in Rehabilitation: Systematic Review
Physical Therapy
2015
93
24
Cost-effectiveness of insulin analogues for diabetes mellitus
Cmaj
2009
90
25
Surveillance mammography after treatment of primary breast cancer: a systematic review
Breast
2002
87
26
Cannabis‐based products for pediatric epilepsy: A systematic review
Epilepsia
2019
79
27
Risk factors for revision of total knee arthroplasty: a scoping review
BMC Musculoskeletal Disorders
2016
78
28
CASE STUDIES THAT ILLUSTRATE DISINVESTMENT AND RESOURCE ALLOCATION DECISION-MAKING PROCESSES IN HEALTH CARE: A SYSTEMATIC REVIEW
International Journal of Technology Assessment in Health Care
2013
72
29
Atypical antipsychotics for insomnia: a systematic review
Sleep Medicine
2016
72
30
Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness
Clinical Therapeutics
2002
60
31
Preoperative Skin Antiseptic Preparations for Preventing Surgical Site Infections: A Systematic Review
Infection Control and Hospital Epidemiology
2012
60
32
When to replicate systematic reviews of interventions: consensus checklist
BMJ, The
2020
58
33
Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis
Cmaj
1998
58
34
Transcutaneous Electrical Nerve Stimulation (TENS): A Technology Assessment
International Journal of Technology Assessment in Health Care
1996
55
35
Methods for Developing Evidence Reviews in Short Periods of Time: A Scoping Review
PLoS ONE
2016
54
36
How well do search filters perform in identifying economic evaluations in MEDLINE and EMBASE
International Journal of Technology Assessment in Health Care
2009
53
37
A Comparative Review of Pharmacoeconomic Guidelines
Pharmacoeconomics
1995
51
38
Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis
BMJ Open
2019
51
39
Clinical effectiveness of rapid tests for methicillin resistant Staphylococcus aureus(MRSA) in hospitalized patients: a systematic review
BMC Infectious Diseases
2011
47
40
Patients’ perspectives can be integrated in health technology assessments: an exploratory analysis of CADTH Common Drug Review
Research Involvement and Engagement
2016
47
41
An Economic Evaluation of Finasteride for Treatment of Benign Prostatic Hyperplasia
Pharmacoeconomics
1996
46
42
Optimizing the use of prescription drugs in Canada through the Common Drug Review
Cmaj
2008
45
43
Systematic review of economic evidence on stroke rehabilitation services
International Journal of Technology Assessment in Health Care
2005
43
44
Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus
Journal of Rheumatology
2018
43
45
The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals
Pharmacoeconomics
1999
42
46
Bringing regenerative medicines to the clinic: the future for regulation and reimbursement
Regenerative Medicine
2015
41
47
Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention
Canadian Journal of Cardiology
2007
40
48
Use of economic evaluation guidelines: 2 years’ experience in Canada
1998
37
49
The ‘Top 10’ Challenges for Health Technology Assessment: INAHTA Viewpoint
International Journal of Technology Assessment in Health Care
2020
36
50
Antimicrobial stewardship in rural nursing homes: Impact of interprofessional education and clinical decision tool implementation on urinary tract infection treatment in a cluster randomized trial
Infection Control and Hospital Epidemiology
2019
35
site/software ©
exaly
; All materials licenced under
CC by-SA
.